Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Transplantation | 4 | 2020 | 369 | 1.250 |
Why?
|
| Asthma | 6 | 2021 | 876 | 1.060 |
Why?
|
| Energy Metabolism | 4 | 2016 | 994 | 0.900 |
Why?
|
| Arginine | 4 | 2016 | 498 | 0.860 |
Why?
|
| Citrulline | 3 | 2015 | 108 | 0.840 |
Why?
|
| Fungi | 2 | 2021 | 146 | 0.830 |
Why?
|
| Allergens | 2 | 2021 | 247 | 0.780 |
Why?
|
| Transplant Recipients | 2 | 2021 | 322 | 0.760 |
Why?
|
| Burnout, Professional | 1 | 2023 | 206 | 0.700 |
Why?
|
| Nitric Oxide | 4 | 2015 | 644 | 0.690 |
Why?
|
| Fibrinolysis | 1 | 2019 | 63 | 0.680 |
Why?
|
| Tacrolimus | 1 | 2020 | 342 | 0.660 |
Why?
|
| Drug Monitoring | 1 | 2020 | 337 | 0.630 |
Why?
|
| Pleura | 1 | 2019 | 127 | 0.630 |
Why?
|
| Pleural Effusion | 1 | 2019 | 201 | 0.600 |
Why?
|
| Shock, Septic | 2 | 2009 | 184 | 0.590 |
Why?
|
| Catheterization | 1 | 2019 | 410 | 0.570 |
Why?
|
| Drainage | 1 | 2019 | 420 | 0.570 |
Why?
|
| Immunity, Innate | 1 | 2021 | 677 | 0.560 |
Why?
|
| Graft Rejection | 1 | 2020 | 834 | 0.540 |
Why?
|
| Surgeons | 1 | 2023 | 527 | 0.540 |
Why?
|
| Sepsis | 2 | 2013 | 657 | 0.530 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 1026 | 0.500 |
Why?
|
| Nutritional Requirements | 1 | 2015 | 185 | 0.480 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 723 | 0.450 |
Why?
|
| Weight Gain | 1 | 2016 | 463 | 0.450 |
Why?
|
| Enterocytes | 1 | 2013 | 68 | 0.440 |
Why?
|
| Glutamine | 1 | 2013 | 300 | 0.390 |
Why?
|
| Rest | 1 | 2011 | 70 | 0.390 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 4355 | 0.380 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 132 | 0.360 |
Why?
|
| Tuberculosis | 1 | 2016 | 555 | 0.360 |
Why?
|
| Glucose | 2 | 2011 | 1247 | 0.310 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 318 | 0.310 |
Why?
|
| Carbon Isotopes | 3 | 2015 | 332 | 0.290 |
Why?
|
| Models, Biological | 1 | 2015 | 3242 | 0.270 |
Why?
|
| Proteins | 2 | 2011 | 1953 | 0.260 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 582 | 0.250 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2018 | 118 | 0.250 |
Why?
|
| Leucine | 3 | 2013 | 352 | 0.250 |
Why?
|
| Nitrogen Isotopes | 2 | 2015 | 60 | 0.240 |
Why?
|
| Th2 Cells | 3 | 2021 | 256 | 0.240 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 445 | 0.230 |
Why?
|
| Depersonalization | 1 | 2023 | 15 | 0.230 |
Why?
|
| Antigens, Fungal | 1 | 2021 | 39 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 38022 | 0.190 |
Why?
|
| Female | 18 | 2021 | 142305 | 0.180 |
Why?
|
| Middle Aged | 12 | 2020 | 86548 | 0.180 |
Why?
|
| Male | 15 | 2021 | 123347 | 0.180 |
Why?
|
| Warfarin | 1 | 2021 | 152 | 0.180 |
Why?
|
| Humans | 23 | 2023 | 262269 | 0.170 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2018 | 10 | 0.160 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2018 | 22 | 0.160 |
Why?
|
| Pectoralis Muscles | 1 | 2017 | 27 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2021 | 1554 | 0.140 |
Why?
|
| Pulmonary Atelectasis | 1 | 2017 | 46 | 0.140 |
Why?
|
| Adult | 12 | 2020 | 78181 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 314 | 0.140 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2017 | 81 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2021 | 1227 | 0.130 |
Why?
|
| Indicator Dilution Techniques | 1 | 2015 | 22 | 0.130 |
Why?
|
| Isotopes | 1 | 2015 | 33 | 0.130 |
Why?
|
| Jamaica | 1 | 2015 | 30 | 0.130 |
Why?
|
| Ornithine | 1 | 2015 | 39 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2021 | 791 | 0.130 |
Why?
|
| Acute Disease | 1 | 2020 | 2431 | 0.130 |
Why?
|
| Deuterium | 1 | 2015 | 111 | 0.130 |
Why?
|
| Demography | 1 | 2016 | 438 | 0.130 |
Why?
|
| Exhalation | 1 | 2015 | 60 | 0.130 |
Why?
|
| Phenylalanine | 1 | 2015 | 142 | 0.130 |
Why?
|
| Meals | 1 | 2015 | 66 | 0.120 |
Why?
|
| India | 1 | 2015 | 305 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 139 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 4338 | 0.110 |
Why?
|
| Splanchnic Circulation | 1 | 2013 | 53 | 0.110 |
Why?
|
| Lung | 2 | 2021 | 3168 | 0.110 |
Why?
|
| Body Composition | 1 | 2015 | 595 | 0.100 |
Why?
|
| Radioactive Tracers | 1 | 2011 | 30 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2017 | 721 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 5724 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2011 | 6103 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2018 | 1162 | 0.090 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2010 | 80 | 0.090 |
Why?
|
| Breath Tests | 1 | 2010 | 175 | 0.090 |
Why?
|
| Aged | 5 | 2020 | 70370 | 0.080 |
Why?
|
| Mitochondria | 1 | 2016 | 1281 | 0.080 |
Why?
|
| Glycolysis | 1 | 2011 | 523 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 1379 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2334 | 0.070 |
Why?
|
| Biomarkers | 3 | 2018 | 5055 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 1082 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 14914 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 229 | 0.070 |
Why?
|
| Prognosis | 3 | 2019 | 21737 | 0.070 |
Why?
|
| Kinetics | 1 | 2009 | 2041 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 2450 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5538 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 941 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 6308 | 0.060 |
Why?
|
| Quality of Life | 1 | 2017 | 4583 | 0.060 |
Why?
|
| Liver | 1 | 2013 | 2904 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2018 | 11972 | 0.040 |
Why?
|
| United States | 1 | 2016 | 15581 | 0.040 |
Why?
|
| Algorithms | 1 | 2010 | 3890 | 0.040 |
Why?
|
| Pregnancy | 1 | 2010 | 7549 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 2514 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 163 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 58 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2016 | 53 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 67 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2016 | 134 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 980 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 261 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 823 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 254 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2017 | 790 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 2325 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1958 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2016 | 721 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 31238 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2397 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 153 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 3272 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4903 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 29996 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 1096 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 5384 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 4809 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2010 | 260 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 2119 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2008 | 33028 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6694 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 6255 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 2156 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 6900 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 9283 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 12239 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 2213 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 7566 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17622 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2892 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 34391 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 59486 | 0.010 |
Why?
|